Sentient LifeSciences, Inc.

United States of America

Back to Profile

1-3 of 3 for Sentient LifeSciences, Inc. Sort by
Query
Aggregations
Jurisdiction
        United States 2
        World 1
IPC Class
A01N 37/12 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group , wherein Cn means a carbon skeleton not containing a ringThio-analogues thereof 1
A01N 37/44 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio-analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio-analogue of a carboxylic group, e.g. amino-carboxylic acids 1
A61K 31/16 - Amides, e.g. hydroxamic acids 1
A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol 1
A61K 31/185 - AcidsAnhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids 1
See more
Found results for  patents

1.

N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress

      
Application Number 15943236
Grant Number 10869846
Status In Force
Filing Date 2018-04-02
First Publication Date 2019-04-18
Grant Date 2020-12-22
Owner SENTIENT LIFESCIENCES, INC. (USA)
Inventor Goldstein, Glenn A.

Abstract

Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.

IPC Classes  ?

  • A61K 31/16 - Amides, e.g. hydroxamic acids
  • C07C 323/41 - Y being a hydrogen or an acyclic carbon atom
  • C07C 323/60 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
  • C07C 233/18 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
  • C07C 233/36 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
  • C07C 233/26 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof

2.

USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF DISEASE AND INJURY

      
Application Number US2013038415
Publication Number 2013/163545
Status In Force
Filing Date 2013-04-26
Publication Date 2013-10-31
Owner SENTIENT LIFESCIENCES, INC. (USA)
Inventor Goldstein, Glenn, A.

Abstract

This disclosure describes methods of use for N-acetylcysteine amide for the treatment of various disorders

IPC Classes  ?

  • A61K 31/195 - Carboxylic acids, e.g. valproic acid having an amino group
  • A61K 31/185 - AcidsAnhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
  • A61K 9/08 - Solutions
  • A61P 9/08 - Vasodilators for multiple indications
  • A61P 27/04 - Artificial tearsIrrigation solutions
  • A61P 27/02 - Ophthalmic agents

3.

N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

      
Application Number 12686106
Grant Number 08354449
Status In Force
Filing Date 2010-01-12
First Publication Date 2010-05-13
Grant Date 2013-01-15
Owner
  • SENTIENT LIFESCIENCES, INC. (USA)
  • SENTIENT LIFESCIENCES, INC. (USA)
Inventor Goldstein, Glenn A.

Abstract

Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.

IPC Classes  ?

  • A01N 37/12 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group , wherein Cn means a carbon skeleton not containing a ringThio-analogues thereof
  • A01N 37/44 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio-analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio-analogue of a carboxylic group, e.g. amino-carboxylic acids